Aggressive Langerhans cell histiocytosis following T‐ALL: Clonally related neoplasms with persistent expression of constitutively active NOTCH1
Open Access
- 14 September 2007
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 83 (2), 116-121
- https://doi.org/10.1002/ajh.21044
Abstract
Langerhans cell histiocytosis (LCH) and related entities are neoplasms of unknown pathogenesis. Here, we describe studies assessing the role of NOTCH1 mutations in LCH, which were based on a case of fatal Langerhans cell tumor after T‐cell acute lymphoblastic leukemia (T‐ALL). Although the two types of neoplasm in this patient were temporally and pathologically distinct, molecular analyses showed that they harbored the same T‐cell receptor gene rearrangements and two activating NOTCH1 mutations involving exons 27 and 34. The exon 27 mutation altered a conserved cysteine residue in the N‐terminal portion of the NOTCH1 heterodimerization domain, while the mutation in exon 34 introduced a premature stop codon that results in the deletion of C‐terminal negative regulatory PEST domain. Analysis of cDNA prepared from the aggressive Langerhans cell tumor showed that the NOTCH1 mutations were aligned in cis, a configuration that caused synergistic increases in NOTCH1 signal strength in reporter gene assays. Immunohistochemistry confirmed that the Langerhans cell tumor also expressed NOTCH1 protein. Although these data suggested that NOTCH1 mutations might contribute to the pathogenesis of typical sporadic LCH and related neoplasms occurring in the absence of T‐ALL, an analysis of 24 cases of LCH and Rosai–Dorfman Disease occurring in patients without an antecedent history of T‐ALL revealed no mutations. Thus, activating NOTCH1 mutations appear to be unique to aggressive Langerhans cell tumors occurring after T‐ALL. Persistent expression of NOTCH1 in such tumors suggests that Notch pathway inhibitors could have a role in the treatment of these unusual neoplasms. Am. J. Hematol., 2008.Keywords
This publication has 20 references indexed in Scilit:
- Notch signalling: a simple pathway becomes complexNature Reviews Molecular Cell Biology, 2006
- Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-BBlood, 2006
- Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironmentBlood, 2005
- Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosisThe Lancet Oncology, 2005
- REGULATION OF LYMPHOID DEVELOPMENT, DIFFERENTIATION, AND FUNCTION BY THE NOTCH PATHWAYAnnual Review of Immunology, 2005
- Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic LeukemiaScience, 2004
- Notch signaling is necessary but not sufficient for differentiation of dendritic cellsBlood, 2003
- THE RELATION OF LANGERHANS CELL HISTIOCYTOSIS TO ACUTE LEUKEMIA, LYMPHOMAS, AND OTHER SOLID TUMORSHematology/Oncology Clinics of North America, 1998
- Langerhans Cell (Eosinophilic) GranulomatosisThe American Journal of Surgical Pathology, 1996
- Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative DiseaseNew England Journal of Medicine, 1994